An assessment score for each Virginia locality (counties and independent cities) is compared to the state score. If a locality received a score higher than the state score, it is considered at higher need for drug overdose-related outcomes and substance use. Localities with higher need may require more resources and support for prevention and intervention services.
These data can be used to inform public health action to reduce and prevent drug overdose. This tool does not assess a locality’s capacity or ability to implement drug overdose prevention and intervention strategies. Communities may also want to work with other local data, existing programs and partnerships, and known areas of increased need when deciding on prevention approaches that best fit their communities. No matter the assessment score, drug overdose and substance use affect all communities. Together with local and state partners, VDH's goal is to support all communities in their efforts to reduce the harms connected with drug use as resources allow.
The table below contains the same information in a table format.
- Data in the table can be sorted by locality, health district, or score. Click on the right side of the column title to sort the selected column.
- Data can be filtered by year in the “Select Year” dropdown menu.
- Download data in Excel and PDF formats.
Learn about the indicators used and how each locality is scored in the Scoring & Methodology document.
Find more information about the needs assessment tool through Frequently Asked Questions.
More Resources:
- Substance Use Disorder Services, including information about Community Service Boards, which provide access to treatment for substance use disorder across Virginia.
- Substance Use Disorder Prevention and Recovery, which helps Virginians affected by substance use disorder find resources related to treatment and recovery.
- Virginia Opioid Abatement Authority
- Learn more about Virginia’s response to the opioid epidemic at Curb The Crisis.
The table below contains the same information in a table format.
- Data in the table can be sorted by locality, health district, or score. Click on the right side of the column title to sort the selected column.
- Data can be filtered by year in the “Select Year” dropdown menu.
- Download data in Excel and PDF formats.
Neonatal abstinence syndrome (NAS) is when babies are exposed to certain drugs in the womb before birth.
Opioid use disorder (OUD) is chronic opioid misuse. This misuse can lead to harmful health outcomes. The use of opioids during pregnancy may cause NAS symptoms for the baby when they are born. OUD is a chronic condition, but treatment options are available.
Maternal Opioid-Related Diagnoses (MOD) Rate is the number of maternal opioid-related diagnoses per 1,000 delivery hospitalizations.
NAS: Counts and rates of infants born with Neonatal abstinence syndrome (NAS) based on inpatient hospitalization records were identified by ICD-9-CM diagnosis code 779.5 (drug withdrawal syndrome in newborn) and ICD-10-CM diagnosis code P96.1 (neonatal withdrawal symptoms from maternal use of drugs of addiction) present on the record for Virginia residents only. Data for 2016 and onward are based on ICD-10-CM.
Possible iatrogenic cases, identified by ICD-9-CM diagnosis codes 765.00-765.05, 770.7, 772.1x, 777.5x, 777.6 and 779.7, were excluded from the numerator. Birth hospitalizations were identified by ICD-9-CM diagnosis codes V30.xx-V39.xx, where the 4th and 5th digit is either 00, 01, 10 or 11, and ICD-10-CM diagnosis codes of Z38.00, Z38.01, Z38.1, Z38.2, Z38.30, Z38.31, Z38.4, Z38.5, Z38.61, Z38.62, Z38.63, Z38.64, Z38.65, Z38.66, Z38.68, Z38.69, Z38.7, or Z38.8. Those with an indication of transfer from another hospital were excluded to avoid duplication. NAS case data presented here are derived from data provided by Virginia Health Information (VHI) to the Virginia Department of Health (VDH) Office of Information Management (OIM).
NAS counts represented on this dashboard are not suppressed.
OUD: Opioid Use Disorder (OUD) counts and rates are based on inpatient hospitalization records were identified from diagnoses of opioid dependence and nondependent opioid abuse present on the record for Virginia residents only. OUD counts represented on this dashboard are not suppressed.
ICD-10-CM codes for Opioid Use Disorder (F11.20, F11.21, F11.220, F11.221, F11.222, F11.229, F11.23, F11.24, F11.250, F11.251, F11.259, F11.281, F11.282, F11.288, F11.29, F11.10, F11.120, F11.121, F11.122, F11.129, F11.14, F11.150, F11.151, F11.159, F11.181, F11.182, F11.188, F11.19). ICD-10-CM code for Long Term Use of Opioid Analgesics (Z79.891), and ICD-10-CM codes for Unspecified Opioid Use (F1190, F11920, F11921, F11922, F11929, F1193, F1194, F11950, F11951, F11959, F11981, F11982, F11988, F1199).
- Anbalagan, S., Falkowitz, D., & Mendez, M. (2024). Neonatal Abstinence Syndrome. StatPearls. National Library of Medicine, National Center for Biotechnology Information. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK551498/
- Association of State and Territorial Health Officials (ASTHO). Neonatal Abstinence Syndrome: How States Can Help Advance the Knowledge Base for Primary Prevention and Best Practices of Care. 2014. http://www.astho.org/prevention/nas-neonatal-abstinence-report/
- Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid Use Disorder Documented at Delivery Hospitalization — United States, 1999–2014. MMWR Morb Mortal Wkly Rep 2018;67:845–849. DOI: http://dx.doi.org/10.15585/mmwr.mm6731a1
- Ko JY, Wolicki S, Barfield WD, et al. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morb Mortal Wkly Rep 2017;66:242–245. DOI: http://dx.doi.org/10.15585/mmwr.mm6609a2
- Opioid Use During Pregnancy | CDC. (2019, July 1). Retrieved from https://www.cdc.gov/pregnancy/opioids/index.html.
- Patrick SW, Shumacher RE, Benneyworth BD et al. Neonatal Abstinence Syndrome and Associated Health Care Expenditures, 2000-2009. JAMA. 2012 May 9. 307(18):1934-40. http://jamanetwork.com/journals/jama/fullarticle/1151530
- Substance Use During Pregnancy | CDC. (2019, July 24). Retrieved from https://www.cdc.gov/reproductivehealth/maternalinfanthealth/substance-abuse/substance-abuse-during-pregnancy.htm.
For additional information about drug overdose and substance use, email overdose@vdh.virginia.gov.